ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Clinical trial NCT06320431 · RECRUITING

Trial details

NCT number: NCT06320431
Sponsor: University of Calgary
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke AIS Stroke Acute Stroke, Acute, Stroke Ischemic

Start date: 2024-09-26
Primary completion: 2030-09-30
Enrollment: 4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.